UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

The pharmacy benefit manager (PBM) industry is under pressure to shift to models that avoid conflicts of interest and ...

Andrew Witty had been CEO of UnitedHealth Group for four years ... which comes a few months after the head of its insurance division was shot and killed in New York, allegedly as a protest ...

President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by special interests.

A short-lived bump in tariff-driven inflation could pass quickly enough to allow U.S. interest-rate cuts later this year, especially if tariffs themselves ease, Fed governor Christopher Waller said.

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

UnitedHealth raised its dividend and replaced its CEO amid scrutiny over Medicare billing and a nearly 40% stock decline this ...